University Hospital Charité Berlin- New Principal Investigator

As of June 2026, Dr. Eva Vanessa Schrezenmeier  has assumed the role of Principal Investigator for the STOP-PKD Study, succeeding Prof. Jan Halbritter.

The  team remains always available to support patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who are interested in learning more about the study. Patients may contact the Berlin trial site to schedule an appointment and receive detailed information about the trial, including eligibility requirements and potential participation.

 Phone: +4930450514183

Email:  nephrologie-studien@charite.de